FDA clears IL's point-of-care bilirubin test
This article was originally published in Clinica
A total bilirubin (tBili) test developed by Instrumentation Laboratory (IL) has received 510(k) clearance from the US FDA. Excess bilirubin in newborns can lead to jaundice, a common condition in neonates. However, some infants progress to severe hyperbilirubinaemia which can cause kernicterus – a form of irreversible brain damage.